| Megan French, | |
|
393 Independence Ln, Dumas, AR 71639-9702 | |
| (870) 382-0500 | |
| Not Available |
| Full Name | Megan French |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 393 Independence Ln, Dumas, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942898390 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD14217 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan French, 301 Highway 65 S, Dumas, AR 71639-2335 Ph: (870) 382-0500 | Megan French, 393 Independence Ln, Dumas, AR 71639-9702 Ph: (870) 382-0500 |
News Archive
The research team led by Prof. WEI Haiming and Prof. TIAN Zhigang from Division of Life Sciences and Medicine, University of Science and Technology of China of the Chinese Academy of Sciences, collaborating with the research group led by Prof. SUN Zimin from the First Affiliated Hospital of USTC revealed the pathological mechanism of severe pre-engraftment syndrome (PES) after umbilical cord blood transplantation, not only providing a treatment strategy for patients with PES, but significantly guiding for further improvement in the curative effect of unrelated cord blood transplantation (UCBT).
GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced the unveiling of its new population health management solution, NextGen Population Health (PH), to help providers meet Patient Centered Medical Home (PCMH) and Accountable Care Organization (ACO) goals, including improving quality, collaborative care, patient engagement and measurement for better health outcomes.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced it has received two important approvals required to conduct its RCS-01 phase 1 human clinical trial.
› Verified 4 days ago
Mr. Eugene H Lee, Jr, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 W Choctaw St, Dumas, AR 71639 Phone: 870-382-4007 Fax: 870-382-4008 | |
Dr. Cheryl R. Stimson, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Highway 65 S, Dumas, AR 71639 Phone: 870-382-0500 Fax: 870-382-6709 | |
William Clay Canada Jr., R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 W Waterman St, Dumas, AR 71639 Phone: 870-382-4343 | |
Dr. Tammy L. Kellebrew, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Porter St, Dumas, AR 71639 Phone: 870-814-3399 | |
Dr. Waltin Zomaya, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Highway 65 S, Dumas, AR 71639 Phone: 870-382-0500 |